Display Settings:

Format

Send to:

Choose Destination
    Pediatr Pulmonol. 2000 Apr;29(4):321-4.

    Improvement of disseminated lymphangiomatosis with recombinant interferon therapy.

    Source

    Section of Hematology/Oncology, Division of Pediatrics, Ste-Justine Hospital, University of Montreal, Montreal, Canada.

    Abstract

    Disseminated lymphangiomatosis is a rare disorder with a poor prognosis. We present a case involving a 3-year-old boy who presented with pulmonary infiltrates, multiple lytic lesions of the ribcage, and small cystic lesions in the spleen. Open-lung and bone biopsies revealed disseminated lymphangiomatosis. Significant clinical and radiologic improvement were observed and persisted after 28 months of treatment with recombinant interferon alpha-2b (IFN alpha-2b). No significant toxicity has been observed.

    Copyright 2000 Wiley-Liss, Inc.

    PMID:
    10738021
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for John Wiley & Sons, Inc.

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk